200 related articles for article (PubMed ID: 26104281)
1. Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2.
Stivaros SM; Stemmer-Rachamimov AO; Alston R; Plotkin SR; Nadol JB; Quesnel A; O'Malley J; Whitfield GA; McCabe MG; Freeman SR; Lloyd SK; Wright NB; Kilday JP; Kamaly-Asl ID; Mills SJ; Rutherford SA; King AT; Evans DG
J Med Genet; 2015 Aug; 52(8):557-62. PubMed ID: 26104281
[TBL] [Abstract][Full Text] [Related]
2. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma.
Irving RM; Moffat DA; Hardy DG; Barton DE; Xuereb JH; Maher ER
Hum Mol Genet; 1994 Feb; 3(2):347-50. PubMed ID: 8004107
[TBL] [Abstract][Full Text] [Related]
3. Significance of Vestibular Testing on Distinguishing the Nerve of Origin for Vestibular Schwannoma and Predicting the Preservation of Hearing.
He YB; Yu CJ; Ji HM; Qu YM; Chen N
Chin Med J (Engl); 2016 Apr; 129(7):799-803. PubMed ID: 26996474
[TBL] [Abstract][Full Text] [Related]
4. Bilateral intracochlear schwannomas in a patient with no genetic or clinical features of neurofibromatosis type 2.
Withers S; Plontke SK; Boeddinghaus R; Kuthubutheen J; Atlas M
HNO; 2020 Jan; 68(Suppl 1):60-64. PubMed ID: 31598774
[TBL] [Abstract][Full Text] [Related]
5. [Bilateral intracochlear schwannomas in a patient with no genetic or clinical features of neurofibromatosis type 2. German version].
Withers S; Plontke SK; Boeddinghaus R; Kuthubutheen J; Atlas M
HNO; 2020 Jul; 68(7):534-538. PubMed ID: 31758201
[TBL] [Abstract][Full Text] [Related]
6. Outcome from surgery for vestibular schwannomas in children.
MacNally SP; Rutherford SA; King AT; Freeman S; Thorne J; Mawman D; O'Driscoll MP; Evans DG; Ramsden RT
Br J Neurosurg; 2009 Jun; 23(3):226-31. PubMed ID: 19533454
[TBL] [Abstract][Full Text] [Related]
7. Influence of nerve of origin and tumor size of vestibular schwannoma on dynamic posturography findings.
Gouveris H; Akkafa S; Lippold R; Mann W
Acta Otolaryngol; 2006 Dec; 126(12):1281-5. PubMed ID: 17101589
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology of vestibular schwannomas.
Chang LS; Welling DB
Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
Mohyuddin A; Neary WJ; Wallace A; Wu CL; Purcell S; Reid H; Ramsden RT; Read A; Black G; Evans DG
J Med Genet; 2002 May; 39(5):315-22. PubMed ID: 12011146
[TBL] [Abstract][Full Text] [Related]
10. Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas.
Cumpston EC; Rhodes SD; Yates CW
Curr Oncol Rep; 2023 May; 25(5):531-537. PubMed ID: 36933171
[TBL] [Abstract][Full Text] [Related]
11. Preoperative prediction of vestibular schwannoma's nerve of origin with posturography and electronystagmography.
Borgmann H; Lenarz T; Lenarz M
Acta Otolaryngol; 2011 May; 131(5):498-503. PubMed ID: 21162660
[TBL] [Abstract][Full Text] [Related]
12. Video Head Impulse Test to Preoperatively Identify the Nerve of Origin of Vestibular Schwannomas.
Constanzo F; Sens P; Teixeira BCA; Ramina R
Oper Neurosurg (Hagerstown); 2019 Mar; 16(3):319-325. PubMed ID: 29750273
[TBL] [Abstract][Full Text] [Related]
13. The comparison between the growth fraction of bilateral vestibular schwannomas in neurofibromatosis 2 (NF2) and unilateral vestibular schwannomas using the monoclonal antibody MIB 1.
Aguiar PH; Tatagiba M; Samii M; Dankoweit-Timpe E; Ostertag H
Acta Neurochir (Wien); 1995; 134(1-2):40-5. PubMed ID: 7668124
[TBL] [Abstract][Full Text] [Related]
14. Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas.
Dewan R; Pemov A; Kim HJ; Morgan KL; Vasquez RA; Chittiboina P; Wang X; Chandrasekharappa SC; Ray-Chaudhury A; Butman JA; Stewart DR; Asthagiri AR
Neuro Oncol; 2015 Apr; 17(4):566-73. PubMed ID: 25452392
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2.
Mautner VF; Nguyen R; Kutta H; Fuensterer C; Bokemeyer C; Hagel C; Friedrich RE; Panse J
Neuro Oncol; 2010 Jan; 12(1):14-8. PubMed ID: 20150363
[TBL] [Abstract][Full Text] [Related]
16. cDNA microarray analysis of vestibular schwannomas.
Welling DB; Lasak JM; Akhmametyeva E; Ghaheri B; Chang LS
Otol Neurotol; 2002 Sep; 23(5):736-48. PubMed ID: 12218628
[TBL] [Abstract][Full Text] [Related]
17. Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype.
Aghi M; Kluwe L; Webster MT; Jacoby LB; Barker FG; Ojemann RG; Mautner VF; MacCollin M
J Neurosurg; 2006 Feb; 104(2):201-7. PubMed ID: 16509493
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
[TBL] [Abstract][Full Text] [Related]
19. Linear accelerator radiosurgery for treatment of vestibular schwannomas in neurofibromatosis 2.
Kuo YH; Roos D; Brophy BP
J Clin Neurosci; 2008 Jul; 15(7):744-8. PubMed ID: 18403208
[TBL] [Abstract][Full Text] [Related]
20. Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2.
Baser ME; Makariou EV; Parry DM
J Neurosurg; 2002 Feb; 96(2):217-22. PubMed ID: 11838793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
